Try our Advanced Search for more refined results

Expert Analysis

How Bowman V. Monsanto May Wreak Havoc On Biotechnology

Law360, New York (April 15, 2013, 1:03 PM EDT) -- On Feb. 19, 2013, the U.S. Supreme Court heard oral argument in Bowman v. Monsanto Company, a case involving the applicability of patent exhaustion to replicating technologies. The U.S. Supreme Court's decision (likely to be issued by June) has the potential to have enormous impact on any life sciences company who makes, sells, uses or purchases self-replicating biotechnology (e.g., bacteria, cell lines, plasmids, microorganisms, synthetic molecules and other human-made living organisms) for research, diagnostic testing and/or industrial scale manufacturing....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!